CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

Staying on PrEP is Significantly Different for PrEP Users With Commercial Insurance Versus Medicaid

Young adults, blacks, cisgender women, and people in rural areas, as well as people on Medicaid, were less likely to persist on PrEP.

By Stephen Hicks

CROI 2019: What News to Expect in HIV Science and Policy

TheBodyPro is covering all the latest in HIV science at the biggest annual gathering of HIV researchers in the U.S. Here's a preview of what's to come.

By Sony Salzman

Retaining Patients in PrEP Care Faces Many Hurdles, Studies Show

Most people who could benefit from pre-exposure prophylaxis are not accessing it, the U.S. Centers for Disease Control and Prevention revealed at this year's Conference on Retroviruses and Opportunistic Infections.

By Barbara Jungwirth

Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence

When is a pre-exposure prophylaxis (PrEP) failure actually a provider failure? And how do we tell the difference?

By Damon L. Jacobs, L.M.F.T.

CDC: Few People Who Could Benefit From PrEP Are Using It

The CDC has released new data at the Conference on Retroviruses and Opportunistic Infections (CROI) estimating that only a small percentage of people most at risk for HIV infection have actually been prescribed pre-exposure prophylaxis (PrEP).

By Kenyon Farrow

PREP in Pregnancy Does Not Increase Poor Birth Outcomes

No increase in poor birth outcomes with PrEP used throughout pregnancy in the Partners Demonstration project.

By Polly Clayden for HIV i-Base

Frame PrEP as Part of a 'Healthy Sex Life' for Better Adherence

Brief, empowering messaging around pre-exposure prophylaxis (PrEP) can lead to better medication adherence, new research has found.

By Emily Newman for BETA

Running a PrEP Clinic in a Community Pharmacy Setting

For one pharmacy in Seattle, the pharmacist plays multiple roles, doing everything from the HIV testing, to the patient education, to the prescribing of PrEP.

By Terri Wilder, M.S.W.

PrEP Failure Case Underscores Importance of Regular HIV Testing

On behalf of, Terri Wilder, M.S.W., spoke with Elske Hoornenborg, M.D., who presented a case study of HIV transmission despite good adherence to pre-exposure prophylaxis (PrEP) and no drug resistance, at CROI 2017.

By Terri Wilder, M.S.W.

Safety Important in Pre-Exposure Prophylaxis Trials

"If there is compelling evidence that [a certain agent] works, we stop the trial straight away and let the world know what's going on," says Deborah Donnell, Ph.D.

By Barbara Jungwirth